Prediction Model for Radiation Sensitivity in Children with Cancer

癌症儿童辐射敏感性预测模型

• 批准号: 7894830
• 负责人: Stella Margaret Davies
• 金额: $ 18.5万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-16 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7894830
• 关键词: 21 year old; Address; Adolescent; Adverse effects; Age; Basal cell carcinoma; Biological Markers; Bone Marrow Transplantation; Cancer Survivor; Candidate Disease Gene; Carcinoma; Child; Childhood Cancer Survivor Study; Code; Cohort Studies; Cytotoxic Chemotherapy; DNA; DNA Repair; DNA Repair Gene; DNA Repair Pathway; Data; Data Set; Development; Diagnosis; Dose; Epidemiology; Exposure to; Follow-Up Studies; Frequencies; Future; General Population; Genes; Genetic; Genetic Polymorphism; Genetic Predisposition to Disease; Genotype; Grant; Health; Hematologic Neoplasms; Incidence; Individual; Investigation; Investigator-Initiated Research; Ionizing radiation; Late Effects; Long-Term Survivors; Low Dose Radiation; Malignant Childhood Neoplasm; Malignant Neoplasms; Modeling; Organ; Outcome; Participant; Pathway interactions; Patients; Persons; Population; Predisposition; Radiation; Radiation Tolerance; Radiation therapy; Recording of previous events; Reporting; Request for Proposals; Research Project Grants; Resources; Risk; Risk Factors; Second Primary Neoplasms; Single Nucleotide Polymorphism; Site; Skin Cancer; Solid; Sun Exposure; Survivors; Testing; Therapeutic; Time; Treatment Protocols; Variant; Whole-Body Irradiation; Work; adverse outcome; age difference; base; cancer radiation therapy; cancer risk; carcinogenesis; case control; childhood cancer survivor; cohort; experience; gene environment interaction; genetic profiling; genetic risk factor; high risk; member; outcome forecast; peer; public health relevance; repaired; response; skin color; validation studies

DESCRIPTION (provided by applicant): Survivors of childhood cancer have an increased risk of subsequent malignancy at another site. Previous studies in the Childhood Cancer Survivor Study (CCSS) have shown that the most frequent second malignant neoplasm is basal cell carcinoma (BCC), and that the most significant risk factor for BCC is exposure to therapeutic radiation. These data contrast with incident cases of BCC in the general population, for which the key risk factors are sun exposure and skin color. While it is clear that therapeutic radiation exposure increases risk of BCC in childhood cancer survivors, many are exposed to radiation and do not develop BCC. Thus, to address this inter- individual variation, given common exposures, we hypothesize that biomarkers of genetic susceptibility to BCC as a second malignancy will differ from those reported for incident cases. Furthermore, the occurrence of BCCs in childhood cancer survivors is potentially a marker of persons with increased radiation sensitivity. In this study, we will use a candidate gene approach in a case-control comparison to explore potential biomarkers that predict risk of BCC in childhood cancer survivors. We will validate positive observations from this investigation in two follow-up studies, which examine BCC in radiation technologists and bone marrow transplant survivors, to determine the generalizability of our observations. These validation studies are outside the work scope of this grant but will be key to the application of this approach to broader populations. We have selected a candidate gene approach for this study because the strong epidemiological data implicating ionizing radiation as the primary risk factor supports a hypothesis-driven approach to candidate gene selection. PUBLIC HEALTH RELEVANCE: Childhood cancer survivors have a high risk of developing basal cell carcinoma (BCC), a type of skin cancer, as a long-term side effect of radiation treatment. Some survivors may be genetically susceptible to developing BCC after receiving radiation treatment for their initial cancer. For this research project, we will develop a prediction model, using genetics and treatment history, to potentially help doctors tailor each patient's therapy to minimize radiation if the child has an innate susceptibility to radiation-induced BCC.

描述（由申请人提供）：儿童期癌症的幸存者在其他部位发生后续恶性肿瘤的风险增加。儿童癌症幸存者研究（CCSS）的先前研究表明，最常见的第二种恶性肿瘤是基底细胞癌（BCC），而基底细胞癌最重要的风险因素是暴露于治疗辐射。这些数据与一般人群中的BCC事件病例形成对比，其关键风险因素是阳光照射和肤色。虽然很明显，治疗性辐射暴露会增加儿童癌症幸存者患BCC的风险，但许多人暴露于辐射而不会发展为BCC。因此，为了解决这种个体间的差异，考虑到常见的暴露，我们假设BCC作为第二种恶性肿瘤的遗传易感性的生物标志物将不同于那些报告的事件病例。此外，在儿童癌症幸存者中发生BCC可能是辐射敏感性增加的人的标志。在这项研究中，我们将在病例对照比较中使用候选基因方法来探索预测儿童癌症幸存者BCC风险的潜在生物标志物。我们将在两项后续研究中验证这项调查的积极观察结果，这些研究检查了放射技术人员和骨髓移植幸存者的BCC，以确定我们观察结果的普遍性。这些验证研究超出了这项资助的工作范围，但将是将这种方法应用于更广泛人群的关键。我们选择了一个候选基因的方法进行这项研究，因为强有力的流行病学数据牵连电离辐射作为主要的危险因素支持一个假设驱动的候选基因选择的方法。 公共卫生相关性：儿童癌症幸存者有很高的风险发展为基底细胞癌（BCC），一种皮肤癌，作为放射治疗的长期副作用。一些幸存者可能在接受放射治疗后遗传上容易患上BCC。对于这个研究项目，我们将开发一个预测模型，使用遗传学和治疗史，以帮助医生定制每个患者的治疗，以最大限度地减少辐射，如果孩子对辐射诱导的BCC具有先天易感性。